Recent progress in acute leukemia and myelodysplasia

IF 2.2 4区医学 Q3 HEMATOLOGY

Best Practice & Research Clinical Haematology Pub Date : 2022-12-01 DOI:10.1016/j.beha.2022.101415

Hetty E. Carraway , Daniel A. Pollyea , Eytan M. Stein

引用次数: 0

Abstract

The advances and progress in the understanding and management of acute leukemia and myelodysplasia continue to occur at an exponential rate. While this has led to more therapy options, clinicians and researchers are now facing more challenges in terms of clinical decision-making and more unanswered questions. This paper has outlined some conundrums in acute leukemia and myelodysplasia, and the efforts that are underway to address these.

查看原文本刊更多论文

急性白血病和骨髓异常增生的最新进展

在对急性白血病和骨髓增生的认识和管理方面的进步和进展继续以指数速度发生。虽然这带来了更多的治疗选择，但临床医生和研究人员现在在临床决策方面面临着更多的挑战和更多未解之谜。本文概述了急性白血病和骨髓增生异常的一些难题，以及正在进行的解决这些问题的努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Best Practice & Research Clinical Haematology 医学-血液学

CiteScore

4.20

自引率

0.00%

发文量

审稿时长

35 days

期刊介绍： Best Practice & Research Clinical Haematology publishes review articles integrating the results from the latest original research articles into practical, evidence-based review articles. These articles seek to address the key clinical issues of diagnosis, treatment and patient management. Each issue follows a problem-orientated approach which focuses on the key questions to be addressed, clearly defining what is known and not known, covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the Editor welcomes suggestions from potential authors.